Administration of Saccharomyces boulardii mafic-1701 improves feed conversion ratio, promotes antioxidant capacity, alleviates intestinal inflammation and modulates gut microbiota in weaned piglets

Table 6 Effect of S. boulardii mafic-1701 on the concentrations of SCFAs (mg/kg) in weaned piglets^*

Items	CON	ANT	SB	SEM	P-value
Acetate
Cecum	3724.49	4052.51	3494.39	112.17	0.13
Colon	4102.98	4527.22	4245.64	74.78	0.05
Propionate
Cecum	2241.26	2484.82	2812.71	221.88	0.60
Colon	2686.08^a	3252.93^b	2861.84^a	81.83	< 0.01
Formate
Cecum	36.77	62.54	72.37	6.43	0.06
Colon	58.27	63.13	68.00	4.20	0.67
Isobutyrate
Cecum	2.89^a	5.10^ab	15.60^b	2.42	0.03
Colon	42.35	44.60	28.09	3.26	0.05
Butyrate
Cecum	870.88	1114.59	1204.74	87.96	0.29
Colon	1499.63^a	2105.30^b	1833.76^ab	97.96	0.03
Isovalerate
Cecum	2.15^a	11.67^b	5.47^ab	1.64	0.04
Colon	36.80	36.70	22.72	4.55	0.35
Valerate
Cecum	92.16^a	211.31^b	235.98^b	24.69	0.01
Colon	250.90^a	460.89^b	258.83^a	35.87	0.01

^*Experimental diets were control diet (CON), CON + 75 mg/kg aureomycin (ANT), CON + 1 × 10⁸ CFU/kg S. boulardii mafic-1701 (SB). Cecal and colonic digesta were collected from three piglets per treatment and the concentrations of SCFAs were measured. In the same row, values with different lowercase letter superscripts mean significant difference (P < 0.05)

ISSN: 2049-1891